SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001596770-16-000128
Filing Date
2016-03-28
Accepted
2016-03-28 17:06:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 3-28-16 schedule13g.htm SC 13G 425806
  Complete submission text file 0001596770-16-000128.txt   427330
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 161532872
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G